Have a feature idea you'd love to see implemented? Let us know!

KNSA Kiniksa Pharmaceuticals PE ratio, current and historical analysis

The current price-to-earnings ratio of KNSA can't be determined, as the TTM EPS of -$0.13 is negative. The most recent PE ratio recorded for Kiniksa Pharmaceuticals was 164.42 in March 2024.

KNSA PE ratio history

How has KNSA's PE ratio performed in the past

Over the last three years, the average PE ratio of Kiniksa Pharmaceuticals has been 45.35. In the past three years, KNSA's PE ratio was at its highest in the Mar 2024 quarter at 164.42, with a price of $19.73 and an EPS of $0.12. The Mar 2023 quarter recorded the bottom point at 3.82, with a price of $10.76 and an EPS of $2.82.

Today
N/A
Average
45.35
Median
5.95
Minimum
3.82
Maximum
164.42

Kiniksa Pharmaceuticals PE ratio by year

Maximum annual increase: 1,446.74% in 2023

Year PE ratio PE change Price EPS
2023 87.7 1,446.74% $17.54 $0.2
2022 5.67 N/A $14.98 $2.64
2021 N/A N/A $11.77 -$2.3
2020 N/A N/A $17.67 -$2.61
2019 N/A N/A $11.06 -$2.99
2018 N/A N/A $28.09 -$3.49
2017 N/A N/A N/A -$35.85
2016 N/A N/A N/A -$91.61

Kiniksa Pharmaceuticals PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Sep 2024 N/A N/A $24.99 -$0.13
Jun 2024 N/A N/A $18.67 -$0.15
Mar 2024 164.42 87.48% $19.73 $0.12
Dec 2023 87.7 N/A $17.54 $0.2
Sep 2023 N/A N/A $17.37 -$0.11
Jun 2023 4.24 10.99% $14.08 $3.32
Mar 2023 3.82 -32.63% $10.76 $2.82
Dec 2022 5.67 -8.99% $14.98 $2.64
Sep 2022 6.23 N/A $12.84 $2.06
Jun 2022 N/A N/A $9.69 -$1.61
Mar 2022 N/A N/A $9.94 -$1.93
Dec 2021 N/A N/A $11.77 -$2.3
Sep 2021 N/A N/A $11.39 -$2.58
Jun 2021 N/A N/A $13.93 -$2.8
Mar 2021 N/A N/A $18.51 -$2.84

KNSA average PE ratio chart

What is the average PE ratio of KNSA for the past years
3-year avg
45.35
5-year avg
45.35
10-year avg
N/A
15-year avg
N/A

KNSA PE vs peers

What is KNSA's PE ratio compared to its peers
Stock name PE ratio Market cap
ORMP Oramed Pharmaceuticals Inc 23.64 $104.81M
OLMA Olema Pharmaceuticals Inc N/A $299.09M
OMER Omeros Corp N/A $505.32M
OMGA Omega Therapeutics Inc N/A $10.7M
ONVO Organovo Holdings Inc N/A $5.32M
ORIC Oric Pharmaceuticals Inc N/A $695.08M
KNSA Kiniksa Pharmaceuticals Ltd N/A $1.42B

Frequently asked questions

What is Kiniksa Pharmaceuticals's PE ratio?

The current price to earnings ratio of KNSA can't be calculated, as its EPS of -$0.13 is negative.

What is the 3-year average PE ratio for Kiniksa Pharmaceuticals (KNSA)?

Over the last 3 years, the average price to earnings ratio for KNSA stock is 45.35.

What is the 5-year average PE ratio for Kiniksa Pharmaceuticals (KNSA)?

Over the last 5 years, the average price to earnings ratio for KNSA stock is 45.35.

What is the highest PE ratio for KNSA?

Over the last three years, the quarterly PE ratio reached a historic high of 164.42 in the Mar 2024 quarter.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.